Komori
Zeria Pharmaceutical (4559) · PolicyReframed

Management indicators focused on consolidated revenue, return on equity and the ratio of overseas sales

First written in FY2017. 4 of 6 entries say "Reframed", first in FY2019. Latest entry: FY2026.

6entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseReframedFY2019 – FY20262017: 120172018: 120182019: 120192020: 120202021: 020212022: 020222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies
Managing business performance indicators using sales, ROE and the overseas sales ratioA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「Regarding management metrics, we place particular importance on consolidated net sales, consolidated operating income, and consolidated return on equity.」

    The key management metrics have been reorganized from the previous metrics, including consolidated net sales and the ratio of overseas sales, to three metrics: consolidated net sales, consolidated operating income, and consolidated return on equity.
  2. FY2023ReframedAnnual report

    「Regarding management metrics, we place particular importance on consolidated net sales and the ratio of overseas sales to consolidated net sales.」

    The key management metrics have been reorganized from the combination of consolidated net sales and consolidated return on equity to the combination of consolidated net sales and the ratio of overseas sales to consolidated net sales.
  3. FY2020ReframedAnnual report

    「Regarding management metrics, we place particular importance on consolidated net sales and consolidated return on equity.」

    The disclosure of the key management metrics has been reorganized from the previous three metrics, consolidated net sales, return on equity, and the ratio of overseas sales, to two metrics: consolidated net sales and consolidated return on equity.
  4. FY2019ReframedAnnual report

    「Our group also recognizes the consolidated equity ratio and consolidated return on equity as important management metrics, and will continue working to improve these metrics by increasing capital efficiency and strengthening earnings capacity.」

    In addition to identifying the key management metrics, the company specifies a policy of improving them by increasing capital efficiency and strengthening earnings capacity.
  5. FY2018AdvancedAnnual report

    「At the end of the consolidated fiscal year, the consolidated equity ratio rose 1.1 percentage points from the end of the previous consolidated fiscal year to 56.5%. The consolidated return on equity rose 0.9 percentage points from the end of the previous consolidated fiscal year to 6.5%.」

    The company reported improvements in its consolidated equity ratio and consolidated return on equity, which it considers important management metrics.
  6. FY2017First statedAnnual report

    「Regarding management metrics, we place particular importance on consolidated net sales, consolidated return on equity, and the ratio of overseas sales to consolidated net sales.」

    The company identifies net sales, return on equity, and the ratio of overseas sales as key management metrics, but does not specify concrete targets.
Moved together

"Promotion of Generic Drug Use and Intensifying Competition in the Pharmaceutical Market" moved the same way as this thread, in the same document, in 4 of its 6 moves.

443322★123456
  1. ★This thread
  2. 1Promotion of Generic Drug Use and Intensifying Competition in the Pharmaceutical Market4×
  3. 2Impact of Drug Price Revisions, Healthcare Policy, and Changes in Laws and Regulations4×
  4. 3Further Strengthening of the Financial Position3×
  5. 4Impact of Swiss franc appreciation on sales of overseas products3×
  6. 5Recovery in Revenue, Operating Profit and Net Income2×
  7. 6Addressing Working Capital and Investment Funding Through Internal Funds, Corporate Bonds and Borrowings2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.